Literature DB >> 7474118

Retrovirus infection: effect of time and target cell number.

J R Morgan1, J M LeDoux, R G Snow, R G Tompkins, M L Yarmush.   

Abstract

Using a model amphotropic recombinant retrovirus encoding the Escherichia coli lacZ gene and quantitative assays to measure virus infection, we have determined the effects of time and target cell number on infectivity. Infection of various numbers of NIH 3T3 fibroblasts showed that the extent of lacZ virus infection was dependent on virus concentration and independent of target cell number. These results demonstrate that multiplicity of infection is not an accurate predictor of the efficiency of retroviral infection. Varying the time of viral infection revealed that maximal infection occurred after greater than 24 h of exposure of the cells to the lacZ virus. Half-maximal infection occurred after 5 h of exposure. After 2 h of adsorption at 37 degrees C, the majority of infectious virus was not adsorbed to cells but was unbound and able to infect other cells. These results are discussed in terms of both their relevance to the fundamental biology of retrovirus infection and the use of recombinant retroviruses for retrovirus-mediated gene transfer with purposes of gene therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474118      PMCID: PMC189618     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Human gene therapy.

Authors:  W F Anderson
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

2.  Increased viral titer through concentration of viral harvests from retroviral packaging lines.

Authors:  R W Paul; D Morris; B W Hess; J Dunn; R W Overell
Journal:  Hum Gene Ther       Date:  1993-10       Impact factor: 5.695

3.  Rapid quantitation of recombinant retroviruses.

Authors:  J R Morgan; J Lee; R G Tompkins; M L Yarmush
Journal:  Biotechnol Prog       Date:  1994 Jul-Aug

4.  Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus.

Authors:  D G Miller; R H Edwards; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

5.  A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family.

Authors:  M van Zeijl; S V Johann; E Closs; J Cunningham; R Eddy; T B Shows; B O'Hara
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 6.  The basic science of gene therapy.

Authors:  R C Mulligan
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

7.  Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.

Authors:  R A Morgan; O Nussbaum; D D Muenchau; L Shu; L Couture; W F Anderson
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses.

Authors:  L M Albritton; J W Kim; L Tseng; J M Cunningham
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.

Authors:  D Ott; A Rein
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

10.  Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus.

Authors:  T Yoshimoto; E Yoshimoto; D Meruelo
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  27 in total

1.  Overcoming the phage replication threshold: a mathematical model with implications for phage therapy.

Authors:  Laura M Kasman; Alex Kasman; Caroline Westwater; Joseph Dolan; Michael G Schmidt; James S Norris
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

3.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

4.  Efficient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor.

Authors:  P Kurre; H P Kiem; J Morris; S Heyward; J L Battini; A D Miller
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

5.  Proteoglycans secreted by packaging cell lines inhibit retrovirus infection.

Authors:  J M Le Doux; J R Morgan; R G Snow; M L Yarmush
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  Efficient infection of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector.

Authors:  S Sharma; M Cantwell; T J Kipps; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

7.  Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo.

Authors:  C D Porter; K V Lukacs; G Box; Y Takeuchi; M K Collins
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin.

Authors:  Pedro Lei; Bharat Bajaj; Stelios T Andreadis
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.

Authors:  Anne K Schwarz; Joe Grove; Ke Hu; Christopher J Mee; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

10.  Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.

Authors:  Marion Cornelissen; Edwin J Heeregrave; Fokla Zorgdrager; Georgios Pollakis; William A Paxton; Antoinette C van der Kuyl
Journal:  Arch Virol       Date:  2010-09-24       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.